ST-segment Elevation Myocardial Infarction (STEMI): Clinical Trials

40 trials for ST-segment Elevation Myocardial Infarction (STEMI), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 12 recruiting, 10 unknown, 3 not yet recruiting. 16 Not applicable, 6 Phase 4, 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable16Recruiting 5, Completed 4, Unknown 3, Not yet recruiting 2, Active not recruiting 1, Terminated 1
Phase 46Recruiting 3, Completed 2, Unknown 1
Phase 33Completed 1, Not yet recruiting 1, Unknown 1
Phase 22Completed 1, Recruiting 1

Follow ST-segment Elevation Myocardial Infarction (STEMI): new trials by email Literature Review of ST-segment Elevation Myocardial Infarction (STEMI) trials Research Report on ST-segment Elevation Myocardial Infarction (STEMI)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Thrombus Aspiration in Patients With Acute ST-Segment Elevation Myocardial Infarction: A Prospective, Multicenter, Randomized, Controlled, Single-Blind Clinical Trial
Manual Thrombus Aspiration, Primary Percutaneous Coronary Intervention (PPCI) - ST-segment Elevation Myocardial Infarction (STEMI)
Not applicableNot yet recruitingFirst Affiliated Hospital Xi'an Jiaotong University67602026-04-012026-04-27
AI-Assisted Coronary Syndrome Subtyping From Admission History of Present Illness: A Clinician Reader Study
OCR-Prompt-LLM Information Extraction and Classification Workflow (OCR-Prompt-LLM), Manual Clinical Data Review - Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Acute Coronary Syndromes
CompletedChina National Center for Cardiovascular Diseases102026-02-282026-10-27
Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
Adenosine pre-medication, Standard care - ST-Segment Elevation Myocardial Infarction (STEMI), No-Reflow Phenomenon
Phase 4RecruitingNational Institute of Cardiovascular Diseases, Pakistan11482025-06-012026-04-22
Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy
Bivalirudin, Unfractionated heparin - ST-segment Elevation Myocardial Infarction (STEMI)
Not applicableNot yet recruitingFirst Affiliated Hospital Xi'an Jiaotong University24002025-05-012025-03-06
Coronary Aspiration Catheter Clinical Trial
Aspiration Catheter, Export Advance Aspiration Catheter - ST-segment Elevation Myocardial Infarction (STEMI)
Not applicableRecruitingBrosMed Medical Co., Ltd1442025-02-202025-04-30
Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial
Fexofenadine Hydrochloride, Placebo - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1602025-01-202026-09-16
Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden
rhTNK-tPA, 4-8 mg, Tirofiban - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 4RecruitingHenan Institute of Cardiovascular Epidemiology3002025-01-012026-05-22
A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI
Butylphthalide, Butylphthalide placebo - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 3Not yet recruitingXiangya Hospital of Central South University402024-12-012024-11-26
The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients After ST Elevation Myocardial Infarction
Morning aerobic exercise, Evening aerobic exercise - ST-segment Elevation Myocardial Infarction (STEMI)
Not applicableRecruitingRenJi Hospital2012024-04-302024-12-31
MAchine Learning to Boost the Early Diagnosis of Acute Cardiovascular Conditions
Machine learning based development of a diagnostic tool for acute cardiovascular disease - Acute Cardiovascular Disease, ST-segment Elevation Myocardial Infarction (STEMI)
RecruitingUniversity Hospital, Basel, Switzerland2000002024-04-012025-04-15
Use of Export in Primary Percutaneous Coronary Intervention
Export Catheter, Balloon catheter - ST-segment Elevation Myocardial Infarction (STEMI), Total Occlusion of Coronary Artery
Not applicableActive not recruitingNational Institute of Cardiovascular Diseases, Pakistan3002024-01-152026-04-09
The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction
Anion gap - ST-segment Elevation Myocardial Infarction (STEMI)
UnknownUniversitas Diponegoro802024-01-012024-09-19
The RECOVER IV Trial
Impella CP®, Standard of Care - ST-segment Elevation Myocardial Infarction (STEMI), Cardiogenic Shock
Not applicableTerminatedAbiomed Inc.42023-10-282025-01-29
Predictive Value of NT-proBNP on MACEs After Acute Coronary Syndrome
N-terminal pro-B-type natriuretic peptide (NT-proBNP), high sensitive cardiac troponin T (hs-cTnT) - Acute Coronary Syndrome, ST-segment Elevation Myocardial Infarction (STEMI)
CompletedHaseki Training and Research Hospital2412023-09-012024-08-26
Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
Rivaroxaban 15 MG [Xarelto] - ST-segment Elevation Myocardial Infarction (STEMI), Left Ventricular Thrombus
Not applicableRecruitingJilin University3202023-05-012026-06-01
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
No aspirin (Prasugurel monotherapy), 12-month DAPT - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 4RecruitingKindai University22582023-02-282023-03-01
The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI
Ketotifen Fumarate, standard treatment - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 4UnknownPeking University Third Hospital602022-09-012022-08-23
Atherosclerotic Lesion Proteomics by Harvesting Angioplasty Balloons (ALPHA).
Angina, Stable, Angina, Unstable
UnknownCopenhagen University Hospital, Rigshospitalet2252021-12-012022-04-08
Prolonged Clinical Follow-up of OPTIMA-5
Recombinant Staphylokinase, Normal Saline - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 4CompletedThe First Affiliated Hospital with Nanjing Medical University2102021-10-292024-09-25
Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset
Primary PCI, Optimal medical therapy with primary PCI not performed - ST-segment Elevation Myocardial Infarction (STEMI)
Not applicableUnknownShanghai Zhongshan Hospital3662021-09-092022-06-24

Showing 20 of 40. Sign in to see all of them.

Narrower conditions

ST Elevation Myocardial Infarction (40)  ·  Acute Coronary Syndrome (7)  ·  Non-ST Elevated Myocardial Infarction (7)  ·  Myocardial Infarction (5)  ·  Angina, Unstable (4)  ·  Angina, Stable (3)  ·  Cardiovascular Diseases (3)  ·  Coronary Artery Disease (3)  ·  Diabetes Mellitus (3)  ·  Heart Failure (2)  ·  Anemia (1)  ·  Angina Pectoris (1)  ·  Arterial Occlusive Diseases (1)  ·  Atherosclerosis (1)  ·  Chest Pain (1)

Broader conditions

Heart Diseases (40)  ·  Ischemia (40)  ·  Necrosis (40)  ·  Pathologic Processes (40)  ·  Pathological Conditions, Signs and Symptoms (40)  ·  Infarction (39)  ·  Myocardial Ischemia (39)  ·  Vascular Diseases (39)  ·  Cardiovascular Diseases (37)  ·  Myocardial Infarction (35)  ·  Neurologic Manifestations (6)  ·  Pain (6)  ·  Signs and Symptoms (6)  ·  Angina Pectoris (5)  ·  Chest Pain (5)

Interventions

Standard of Care (2)  ·  2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1)  ·  3-n-butylphthalide (1)  ·  Acid-Base Equilibrium (1)  ·  Angioplasty (1)  ·  Dexmedetomidine (1)  ·  Heparin (1)  ·  Ketotifen (1)  ·  N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester (1)  ·  Rivaroxaban (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Ticagrelor (1)  ·  Tirofiban (1)  ·  bivalirudin (1)

Sponsors

Assiut University (2)  ·  First Affiliated Hospital Xi'an Jiaotong University (2)  ·  National Institute of Cardiovascular Diseases, Pakistan (2)  ·  RenJi Hospital (2)  ·  Shanghai Zhongshan Hospital (2)  ·  Abiomed Inc. (1)  ·  An-Najah National University (1)  ·  BrosMed Medical Co., Ltd (1)  ·  Catcronic Salut SL (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  Chinese PLA General Hospital (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  German Diabetes Center (1)  ·  Guangdong Provincial People's Hospital (1)  ·  Harbin Medical University (1)

Countries

China (15)  ·  Denmark (3)  ·  Germany (3)  ·  United States (3)  ·  Pakistan (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Brazil (1)  ·  Indonesia (1)  ·  Japan (1)  ·  Mauritius (1)  ·  Palestinian Territories (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Adem Az, M.D. (1)  ·  Aly Mohamed, Lecturer (1)  ·  Bo Yu, M.D., FACC (1)  ·  Bruno Faillace, MD (1)  ·  Chengzhi Lu (1)  ·  Cheryl Jones, PhD, RN (1)  ·  Christian Jung, MD, PhD (1)  ·  Dr Fiaza Farooq, FCPS (1)  ·  Gaku Nakazawa, MD, PhD (1)  ·  Gorm M Hansen, MD, PhD (1)  ·  Gregg Stone, MD (1)  ·  James Cotton (1)  ·  Jasper Boeddinghaus, PD Dr. med. (1)

Results publications

PMID 23216571, PMID 23634911, PMID 27703287, PMID 30249382, PMID 30916200, PMID 31129911, PMID 33605111, PMID 34136542, PMID 34765262, PMID 35249841, PMID 35525262, PMID 35618347, PMID 36056877, PMID 37138228, PMID 37548623, PMID 37830268, PMID 37870928, PMID 39226457, PMID 39236724, PMID 39294617, PMID 39484131, PMID 39746473, PMID 40558655, PMID 41314962, PMID 41436299, PMID 41791655, PMID 41821026, PMID 42670955

NIH funding

2018 (1)